INVESTOR'S INFORMATION
21 JULY 2023
Skin that smiles back at you: Sarantis Group Introduces bioten Hydro X-Cell, the new comprehensive skincare and hydration line
Bioten, the beloved skincare brand of Sarantis Group, once again draws inspiration from the power of natural elements and biotechnology, introducing the new comprehensive skincare and hydration line, Bioten Hydro X-Cell! The new bioten Hydro X-Cell line, fully aligned with the Group's strategy, is designed to provide an ultimate, long-lasting hydration experience.
21 JULY 2023
Purchase of own shares
In effect of the article 5 of the 596/2014 Regulation of the European Parliament and of the Council, the company GR. SARANTIS S.A. announces that according to article 49, of the Law 4548/20, and based on the resolutions of the Shareholder's Ordinary General Meeting dated May 31 2022, the Company proceeded on July 20th 2023 to the purchase of 2,400 own shares at the average price of 7.
20 JULY 2023
Purchase of own shares
In effect of the article 5 of the 596/2014 Regulation of the European Parliament and of the Council, the company GR. SARANTIS S.A. announces that according to article 49, of the Law 4548/20, and based on the resolutions of the Shareholder's Ordinary General Meeting dated May 31 2022, the Company proceeded on July 19th 2023 to the purchase of 244 own shares at the average price of 7.
6 JULY 2023
Announcement of regulated information according to the L.3556
The company GR. SARANTIS S.A. announces, according to the articles 3 and 21 of the L.3556/2007 and the provisions of the Regulation (EU) No 596/2014 of the European Parliament and of the Council, that Mr.
5 JULY 2023
Purchase of own shares
In effect of the article 5 of the 596/2014 Regulation of the European Parliament and of the Council, the company GR. SARANTIS S.A. announces that according to article 49, of the Law 4548/20, and based on the resolutions of the Shareholder's Ordinary General Meeting dated May 31 2022, the Company proceeded on July 4th 2023 to the purchase of 15,000 own shares at the average price of 7.
4 JULY 2023
Purchase of own shares
In effect of the article 5 of the 596/2014 Regulation of the European Parliament and of the Council, the company GR. SARANTIS S.A. announces that according to article 49, of the Law 4548/20, and based on the resolutions of the Shareholder's Ordinary General Meeting dated May 31 2022, the Company proceeded on July 3rd 2023 to the purchase of 511 own shares at the average price of 7.
4 JULY 2023
Formation of the Board of Directors into body
The company “GR. SARANTIS S.A.” (hereinafter referred to as the “Company”) announces to the investment community that οn 30.6.2023 Mr Konstantinos Stamatiou of Fokion, executive member of the BoD, and Mr Christos Oikonomou of Ioannis, independent non- executive member of the BoD, submitted their resignations to the Board of Directors.
30 JUNE 2023
Purchase of own shares
In effect of the article 5 of the 596/2014 Regulation of the European Parliament and of the Council, the company GR. SARANTIS S.A. announces that according to article 49, of the Law 4548/20, and based on the resolutions of the Shareholder's Ordinary General Meeting dated May 31 2022, the Company proceeded on June 29th 2023 to the purchase of 12,694 own shares at the average price of 7.
Contact
SARANTIS Group
26, Amaroussiou - Halandriou Street
151 25 Maroussi, Athens, Greece
Tel: +30 210 6173000
Fax: +30 210 6197081
e-mail: group-info@sarantisgroup.com
Connect with us
We're always looking to connect with those who share an interest.Management of Sarantis Group encourages everyone to Speak Up and report any inappropriate behaviour or practice. SARANTIS Group Speak Up
Stay Tuned
Sign up to receive our latest news update!
Sarantis Group © 2026. All rights reserved.
Terms Of Use
| Privacy Policy
| Cookies Policy
| Digital Assistant Terms of Use
Website Design & Development by
